Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions (AlloRé)

Centre Hospitalier Universitaire de la Réunion

Status: Not yet enrolling

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation

Treatments: Other: questionnaire

Study type: Observational

Funder types: Other

Identifiers

NCT05327673

2020/CHU/21

Details and patient eligibility

About

This project aims to document and analyse - with a three-fold anthropological, psychosocial and economical approach - the consequences of the geographical distance from mainland France on the alloSCT on both patients, their caregivers and the healthcare system. It is organised in 3 working packages (WP).

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients diagnosed with hematological malignancy (myeloid acute leukemia, lymphoid acute leukemia, non-hodgkin lymphoma, Hodgkin disease, or myelodysplasic syndrome
• candidate to an allogeneic hematopoietic stem cell transplantation in mainland France ;
• Residing in Reunion Island
• Age >18 year old;
• who accept or not allogeneic hematopoietic
• Able to complete a questionnaire

Exclusion criteria

• Opposition to participation and collection of their data
• Person deprived of liberty by judicial or administrative decision, and person subject to legal protection (guardianship or curators)

Trial design

100 participants in 2 patient groups

patients who accept Allogeneic Hematopoietic Stem Cell Transplantation (alloH SCT)

Treatment:

Other: questionnaire

patients who did not accept Allogeneic Hematopoietic Stem Cell Transplantation (alloH SCT)

Treatment:

Other: questionnaire